Escalon Medical Corp (ESMC): R&D Expense
$753.1K
Year ended 2025-06-30
$668.8K
Trailing 12 months to 2026-03-31
-8.7%
3-year compound annual growth
-7.7%
5-year compound annual growth
-5.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $753.1K | +9.4% | 2025-09-29, From 2024-07-01 |
| 2024-06-30 | $688.2K | -15.9% | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | $818.8K | -17.4% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $991.0K | +11.3% | 2023-10-13, From 2021-07-01 |
| 2021-06-30 | $890.5K | -20.7% | 2022-09-28, From 2020-07-01 |
| 2020-06-30 | $1.12M | +51.7% | 2021-09-27, From 2019-07-01 |
| 2019-06-30 | $739.8K | +47.9% | 2020-09-28, From 2018-07-01 |
| 2018-06-30 | $500.3K | -52.5% | 2019-09-27, From 2017-07-01 |
| 2017-06-30 | $1.05M | -27.4% | 2018-09-28, From 2016-07-01 |
| 2016-06-30 | $1.45M | +11.4% | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | $1.30M | -0.4% | 2016-10-12, From 2014-07-01 |
| 2014-06-30 | $1.31M | +18.2% | 2015-09-29, From 2013-07-01 |
| 2013-06-30 | $1.11M | +10.0% | 2014-09-26, From 2012-07-01 |
| 2012-06-30 | $1.00M | n/c | 2013-09-20, From 2011-07-01 |
| 2011-06-30 | $1.60M | n/a | 2012-09-26, From 2010-07-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $3.94M | +20.5% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.16M | +17.9% |
| electroCore, Inc. (ECOR) | 2024-12-31 | $2.36M | -55.6% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $493.6K | +13.8% |
Compare ESMC, CV, HYPR, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗